Post Allogeneic Stem Cell Transplant (SCT) Cyclophosphamide Improves Progression Free Survival (PFS) in Pts with AML/MDS Treated with CTLA-4 or PD-1 Blockade Prior to SCT
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Betul Oran, Guillermo Garcia-Manero, Rima M. Saliba, Gheath Alatrash, Elias J. Jabbour, Uday Popat, Farhad Ravandi, Tapan M. Kadia, Jorge E. Cortes, Amin M. Alousi, Marina Y. Konopleva, Courtney D. DiNardo, Katy Rezvani, Mansour Alfayez, Elizabeth J. Shpall, Padmanee Sharma, Richard E Champlin, Hagop M. Kantarjian, Naval G. Daver
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2903644696